Astrazeneca ADR Stock
Price
Target price
€77.50
€77.50
0.000%
-
0.000%
€80.00
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Astrazeneca ADR Stock
There is no change in the price for Astrazeneca ADR today.
The community is currently still undecided about Astrazeneca ADR with 1 Buy predictions and 0 Sell predictions.
As a result the target price of 80 € shows a slightly positive potential of 3.23% compared to the current price of 77.5 € for Astrazeneca ADR.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Astrazeneca ADR stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Astrazeneca ADR in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Astrazeneca ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Astrazeneca ADR | 0.000% | -3.125% | 9.155% | 21.094% | 21.094% | 18.502% | 74.550% |
| GSK plc ADR | -0.480% | 0.483% | 1.961% | 26.829% | 26.829% | 23.810% | 7.355% |
| Bayer AG ADR | 0.600% | 12.000% | 32.283% | 78.723% | 69.355% | -37.313% | -28.814% |
| Novo Nordisk A/S ADR | -0.120% | -3.860% | -2.607% | -60.097% | -50.837% | -66.173% | -26.607% |
News
Why AstraZeneca Stock Bumped Higher Today
AstraZeneca (NASDAQ: AZN) stock finished the trading week in style, rising by nearly 3% in value on Friday. That was due to news from the company that it's expanding its manufacturing footprint in
OMP Miami Conference 2025: Transforming Supply Chain Vision into REAL Impact with Human-AI Synergy
MIAMI, FL / ACCESS Newswire / November 20, 2025 / OMP, a global leader in supply chain planning solutions, brought together global supply chain executives, technology innovators, and
Where Will IonQ Be in 10 Years?
Ten years go by quickly. Duke University professors Chris Monroe and Jungang Kim founded IonQ (NYSE: IONQ) in 2015. Their goal was to develop a commercially viable quantum computer. They succeeded.